ArticleProceedings of the National Academy of Sciences of the United States of America2022

Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases.

Nadire Duru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.